Selective thrombocytopenia in children with Wilms tumor: an immune-mediated effect of dactinomycin?
D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D003609:Dactinomycin / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D010976:Platelet Count; D012189:Retrospective Studies; D018570:Risk Assessment; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000453:epidemiology / Q000276:immunology; D009396:Wilms Tumor / Q000175:diagnosis / Q000188:drug therapy*
D003609:Dactinomycin